Found 4 results
Name | Type of Offering | Accepted Date |
---|---|---|
DalCor Pharmaceuticals US, LLC
See All Filings
|
D | 2016-05-13 |
Amount To Be Raised
$110,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001673368
Filed Document
0001673372-16-000001
Exclusions or Exemptions
506b
Accepted Date
2016-05-13
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
DalCor Pharmaceuticals US, LLC
See All Filings
|
D | 2020-05-27 13:29:27 |
Amount To Be Raised
$2,845,541
Associated Brokers / Dealers
N/A
CIK Number
0001673368
Filed Document
0001673368-20-000001
Exclusions or Exemptions
506b
Accepted Date
2020-05-27 13:29:27
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
FLORIDA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
DalCor Pharmaceuticals US, LLC
See All Filings
|
D/A | 2017-05-12 12:14:00 |
Amount To Be Raised
$110,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001673368
Filed Document
0001673368-17-000001
Exclusions or Exemptions
506b
Accepted Date
2017-05-12 12:14:00
Type of Offering
D/A
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
DalCor Pharmaceuticals US, LLC
See All Filings
|
D/A | 2020-09-14 14:21:35 |
Amount To Be Raised
$3,851,699
Associated Brokers / Dealers
N/A
CIK Number
0001673368
Filed Document
0001673368-20-000002
Exclusions or Exemptions
506b
Accepted Date
2020-09-14 14:21:35
Type of Offering
D/A
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
FLORIDA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|